This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Texas Tech University System. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Dhananjay Kumar Singh: Innovator in Tumor Cell Screening Technology
Introduction
Dhananjay Kumar Singh is a notable inventor based in Lubbock, TX (US). He has made significant contributions to the field of medical technology, particularly in the area of tumor cell detection.
Latest Patents
Singh holds a patent for a groundbreaking invention titled "Method and device for label-free, high throughput holographic screening and enumeration of tumor cells in blood." This innovative method includes a laser source, a micro-objective, a pinhole device, a collimating lens, a mirror, and a sample chamber. The device allows for the label-free holographic screening and enumeration of tumor cells in bulk flow. The process involves a collimated laser beam passing through a microchannel, interacting with cells in the sample, and generating a hologram at the detector. A processor then calculates a numerical reconstruction from the hologram, producing a focused image of the cells, which are enumerated based on size and intensity metrics.
Career Highlights
Dhananjay Kumar Singh is affiliated with the Texas Tech University System, where he continues to advance his research and development efforts. His work is pivotal in enhancing the accuracy and efficiency of tumor cell detection, which can have significant implications for cancer diagnostics and treatment.
Collaborations
Some of his notable coworkers include Caroline C Ahrens and Wei Li, who contribute to the collaborative research environment at Texas Tech University System.
Conclusion
Dhananjay Kumar Singh's innovative work in tumor cell screening technology exemplifies the impact of research and invention in the medical field. His contributions are paving the way for advancements in cancer diagnostics and treatment methodologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
